Menu
Subscribe - Individual
Subscribe - Biotech Premium (Corporate)
Home
About Us
Subscribe
Subscribe Individual
Subscribe Biotech Premium (Corporate)
Premium Biotech Coverage
Current News
Special Features
Company Index
Index Table
Summit
19th Bioshares Biotech Summit
Summit History
Contact
Contact Us
Email Alerts
Home
>
Premium Biotech Coverage
>
Current News
Current News
Categories
Categories
Actinogen (ACW)
Adalta (1AD)
Anteris Technologies (AVR)
Aroa Biosurgery (ARX)
Blinklab (BB1)
Blog
Botanix (BOT)
Chimeric Therapeutics (CHM)
Clinuvel Pharmaceuticals (CUV)
Cogstate (CGS)
Dimerix (DXB)
Immuron (IMC)
Imugene (IMU)
Island Pharmaceuticals (ILA)
Neuren Pharmaceuticals (NEU)
Patrys (PAB)
Syntara (SNT) (previously Pharmaxis, PXS)
Uncategorized
February 19th, 2025
Aroa Biosurgery Narrowly Misses Full-Year Guidance
Read More
February 18th, 2025
Immuron Sales Up 70% in First Half
Read More
February 18th, 2025
Leading the Way – Adalta's East to West Roadmap
Read More
February 17th, 2025
Opthea's Phase 3 Results Fast Approaching
Read More
February 14th, 2025
Biotech Sector Resurgence Underway
Read More
January 28th, 2025
Cyclopharm Share Price Up 48%
Read More
January 28th, 2025
Wheels in Motion for Cogstate
Read More
January 28th, 2025
Solid Quarter for Somnomed; Revenue up 20% to $28.5 Million
Read More
January 25th, 2025
Telix Pharmaceuticals' Sales Up 46% with 12th Acquisition Announced
Read More
January 9th, 2025
Dimerix Secures Third Licensing Deal
Read More
Pages
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
